Kaye L Johnston1, John P Farnen, Brian R Manske, Ronald S Go. Show Affiliations » 1. Section of Hematology, Department of Internal Medicine, Gundersen Lutheran Health System La Crosse, Wisconsin, USA.
Abstract
Mesh: See more » Anemia/chemically inducedAnemia/drug therapyAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal/adverse effectsAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy Protocols/adverse effectsAntineoplastic Combined Chemotherapy Protocols/therapeutic useBone Marrow/diagnostic imagingCyclophosphamide/administration & dosageCyclophosphamide/adverse effectsDoxorubicin/administration & dosageDoxorubicin/adverse effectsEpoetin AlfaErythropoietin/adverse effectsErythropoietin/therapeutic useFemaleFilgrastimGranulocyte Colony-Stimulating Factor/adverse effectsGranulocyte Colony-Stimulating Factor/therapeutic useHumansLymphoma, Large B-Cell, Diffuse/diagnostic imagingLymphoma, Large B-Cell, Diffuse/drug therapyMiddle AgedNeutropenia/chemically inducedNeutropenia/drug therapyPolyethylene GlycolsPositron-Emission TomographyPrednisone/administration & dosagePrednisone/adverse effectsRecombinant ProteinsRituximabStomach Neoplasms/diagnostic imagingStomach Neoplasms/drug therapyVincristine/administration & dosageVincristine/adverse effects
Substances: See more » Antibodies, MonoclonalAntibodies, Monoclonal, Murine-DerivedRecombinant ProteinsErythropoietinGranulocyte Colony-Stimulating FactorpegfilgrastimPolyethylene GlycolsRituximabVincristineEpoetin AlfaDoxorubicinCyclophosphamideFilgrastimPrednisone
Year: 2005 PMID: 16464762
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941